Prognosis after salvage treatment for unselected male patients with germ cell tumours.

por Gerl, A., Clemm, C., Schmeller, N., Hartenstein, R., Lamerz, R., Wilmanns, W.
Publicado 1995

Advances in the management of metastatic non-seminomatous germ cell tumours during the cisplatin era: a single-institution experience.

por Gerl, A., Clemm, C., Schmeller, N., Hartenstein, R., Lamerz, R., Wilmanns, W.
Publicado 1996

Release of prostaglandin D2 by murine mast cells: importance of metabolite formation for antiproliferative activity.

por Haberl, C, Hültner, L, Flügel, A, Falk, M, Geuenich, S, Wilmanns, W, Denzlinger, C
Publicado 1998

Sequential resection of residual abdominal and thoracic masses after chemotherapy for metastatic non-seminomatous germ cell tumours.

por Gerl, A., Clemm, C., Schmeller, N., Dienemann, H., Weiss, M., Kriegmair, M., Löhrs, U., Wilmanns, W.
Publicado 1994